Cargando…
Fas Activated Serine-Threonine Kinase Domains 2 (FASTKD2) mediates apoptosis of breast and prostate cancer cells through its novel FAST2 domain
BACKGROUND: Expression of NRIF3 (Nuclear Receptor Interacting Factor-3) rapidly and selectively leads to apoptosis of breast cancer cells. This occurs through binding of NRIF3 or its 30 amino acid Death Domain-1 (DD1) region to the transcriptional repressor, DIF-1 (DD1 Interacting Factor-1). DIF-1 a...
Autores principales: | Das, Sharmistha, Yeung, Kay T, Mahajan, Muktar A, Samuels, Herbert H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256816/ https://www.ncbi.nlm.nih.gov/pubmed/25409762 http://dx.doi.org/10.1186/1471-2407-14-852 |
Ejemplares similares
-
Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis
Publicado: (1995) -
Correlated Mutation Analysis on the Catalytic Domains of Serine/Threonine Protein Kinases
por: Xu, Feng, et al.
Publicado: (2009) -
FASTKD1 and FASTKD4 have opposite effects on expression of specific mitochondrial RNAs, depending upon their endonuclease-like RAP domain
por: Boehm, Erik, et al.
Publicado: (2017) -
Clinical Phenotype of FASTKD2 Mutation
por: Shah, Ritesh, et al.
Publicado: (2021) -
Correction: Correlated Mutation Analysis on the Catalytic Domains of Serine/Threonine Protein Kinases
por: Xu, Feng, et al.
Publicado: (2009)